Opinion: STAT+: How AI can help satisfy FDA’s drug, device diversity requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.
The (FDORA), which was passed as part of the , will encourage greater diversity in clinical trials and help ensure new medications
